HEALIUS LIMITED — Director's Dealing 2021

Nov 21, 2021

Appendix 3Y Change of Director’s Interest Notice

Rule 3.19A.2

Appendix 3Y

Change of Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 30/09/01 Amended 01/01/11

Introduced 30/09/01 Amended 01/01/11
Name of entity	HEALIUS LIMITED
ABN	24 064 530 516

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director	Gordon Richard Davis
Date of last notice	18 September 2018

Part 1 - Change of director’s relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

Direct or indirect interest	Direct
Nature of indirect interest (including registered holder) Note: Provide details of the circumstances giving rise to the relevant interest.	N/A
Date of change	19 November 2021
No. of securities held prior to change	55,759 ordinary shares GR & G Davis Superannuation Fund
Class	NED Share Rights
Number acquired	16,064
Number disposed	N/A
Value/Consideration Note: If consideration is non-cash, provide details and estimated valuation	$80,000 cash equivalent using the volume weighted average price of Ordinary Shares over the five business days immediately following the Healius Limited Annual General Meeting on 21 October 2021, being $4.98.
No. of securities held after change	16,064 NED Share Rights Gordon Davis 55,759 Ordinary Shares GR & G Davis Superannuation Fund

• See chapter 19 for defined terms.

01/01/2011 Appendix 3Y Page 1

Appendix 3Y Change of Director’s Interest Notice

Nature of change

Example: on-market trade, off-market trade, exercise of options, issue of securities under Issue of Securities under the NED Share Plan. dividend reinvestment plan, participation in buyback

Part 2 – Change of director’s interests in contracts Not applicable

Part 3 –[+] Closed period

Part 3 –+Closed period
Were the interests in the securities or contracts detailed above traded during a+closed period where prior written clearance was required?	Not applicable
If so, was prior written clearance provided to allow the trade to proceed during this period?	Not applicable
If prior written clearance was provided, on what date was this provided?	Not applicable

Authorised by the Company Secretary.

Charles Tilley Company Secretary Date: 22 November 2021

• See chapter 19 for defined terms.

Appendix 3Y Page 2

01/01/2011